Ischemic bowel necrosis induced by endothelin-1: An experimental model in rats

S. Miura, I. Kurose, D. Fukumura, M. Suematsu, E. Sekizuka, H. Tashiro, H. Serizawa, H. Asako, M. Tsuchiya

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)


Local intra-arterial administration of endothelin-1 induced small intestinal mucosal damage in rats in a dose-dependent manner. A remarkable decrease in mucosal blood flow (15% of control values) was observed by a laser Doppler flowmetry 10 min after injection of endothelin-1 (1 nmol/kg). Endothelin-1 at this dose induced significant hemorrhagic and necrotic lesions in the small intestinal mucosa 30 min after the injection. Decreased mucosal blood flow was attenuated to some extent by the pretreatment with platelet-activating factor (PAF) inhibitor, CV-6209, superoxide dismutase plus catalase or the calcium antagonist, nicorandil. All these inhibitors significantly prevented the endothelin-1-induced ischemic necrotic damage in the small intestine. These results suggest a potential role of endothelin- 1 in the pathogenesis of ischemic bowel diseases in clinical situations and also the possibility that PAF and oxygen-derived free radicals may be involved as secondary mediators in endothelin-induced intestinal tissue damage.

Original languageEnglish
Pages (from-to)163-172
Number of pages10
Issue number3
Publication statusPublished - 1991


  • endothelin-1
  • ischemic bowel necrosis
  • mucosal blood flow
  • oxygen-derived free radicals
  • platelet-activating factor

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Ischemic bowel necrosis induced by endothelin-1: An experimental model in rats'. Together they form a unique fingerprint.

Cite this